Zometa Lawsuit Results in $10.45M Verdict Over Jaw Damage
A New York jury has awarded $10.45 million to a woman who filed a product liability lawsuit alleging that the bone strengthening drug Zometa caused severe jaw damage.
A New York jury has awarded $10.45 million to a woman who filed a product liability lawsuit alleging that the bone strengthening drug Zometa caused severe jaw damage.
The fourth Fosamax trial in the United States is set to begin this week in New Jersey state court, involving a lawsuit filed by a Florida woman who alleges that…
The estate of a North Carolina woman has been awarded nearly $13 million through a lawsuit over jaw damage from Aredia and Zometa, two chemotherapy drugs.
A New Jersey jury has returned a defense verdict in a Zometa lawsuit brought by a woman who alleged that the bone-strengthening cancer drug caused her to suffer a painful…
The retrial of a Fosamax suit that ended in a mistrial last year has resulted in an $8 million verdict in favor of a plaintiff who claimed that the osteoporosis…
A new trial is scheduled to begin next Tuesday for the Fosamax bellwether case that ended in a mistrial last fall, after a jury could not come to a decision…
A federal judge and a New Jersey judge have cleared the way for about 200 Aredia and Zometa jaw necrosis lawsuits against Novartis Corp. to move forward to trial, rejecting the…
A federal judge has denied attempts by Merck & Co. to have a Fosamax lawsuit thrown out, clearing the way for an April 19 trial to move forward involving allegations that…
U.S. District Judge John Keenan, who is presiding over the consolidated federal Fosamax lawsuits involving claims that the osteoporosis drug caused users to suffer debilitating jaw damage, has scheduled trial…
The judge who is presiding over the consolidated federal Fosamax litigation, which involves claims that Merck & Co. failed to warn that their osteoporosis drug may increase the risk of…